Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
Status:
Completed
Trial end date:
2002-03-27
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of troxacitabine in treating patients who
have blast phase chronic myelogenous leukemia.